MedImmune pulls 13 lots of H1N1 vaccine with decreased potency

12/22/2009 | Los Angeles Times (tiered subscription model)

MedImmune is recalling 4.7 million doses of its intranasal H1N1 flu vaccine that lost potency after shipment. The recall is not related to safety problems, the FDA said, and the 13 batches "passed pre-release testing for safety, purity and potency." Sanofi-Aventis announced a similar recall last week for its H1N1 vaccine for children.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY